Nectar Lifesciences
NECLIFE.NS
$0.41
Share price
-1.56%
Change (1 day)
86.36%
Change (1 year)
Categories
Nectar Lifesciences (NECLIFE.NS) - Cash on Hand
Cash on Hand as of September 2023 : $4.03 M
According to Nectar Lifesciences
's latest financial reports the company has $4.03 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Nectar Lifesciences - Cash on Hand chart (from 2019 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-03-31 | $2.17 M | -9.51% |
| 2022-03-31 | $2.4 M | -31.96% |
| 2021-03-31 | $3.53 M | 24.4% |
| 2020-03-31 | $2.84 M | -9.49% |
| 2019-03-31 | $3.13 M | 108.93% |
| 2018-03-31 | $1.5 M | -28.17% |
| 2017-03-31 | $2.09 M | -62.61% |
| 2016-03-31 | $5.59 M | 3.56% |
| 2015-03-31 | $5.4 M | 215.15% |
| 2014-03-31 | $1.71 M | 42.45% |
| 2013-03-31 | $1.2 M | -76.44% |
| 2012-03-31 | $5.1 M | -83.72% |
| 2011-03-31 | $31.36 M | 7% |
| 2010-03-31 | $29.31 M | 10.05% |
| 2009-03-31 | $26.63 M | -36.55% |
| 2008-03-31 | $41.98 M | 15.33% |
| 2007-03-31 | $36.4 M | 72.88% |
| 2006-03-31 | $21.05 M |